2024年市场监管药品监管工作建议1.加强对药品生产企业的监督检查和管理，保障药品质量和安全。Strengthensupervisionandmanagementofdrugproductionenterprisestoensurethequalityandsafetyofdrugs.2.完善药品流通监管体系，提高药品流通环节监管水平。Improvethedrugdistributionmonitoringsystemandenhancethesupervisionlevelofdrugdistribution.3.加大对药品不良反应和药品安全事件的监测和处置力度。Intensifymonitoringanddisposalofdrugadversereactionsanddrugsafetyincidents.4.完善药品审评审批制度，加快药品审批速度，促进创新药物上市。Improvethedrugreviewandapprovalsystem,acceleratethedrugapprovalprocess,andpromotethemarketentryofinnovativedrugs.5.加强对药品广告和宣传的监管，防止虚假宣传和误导消费者。Strengthentheregulationofdrugadvertisingandpromotiontopreventfalseadvertisingandmisleadingconsumers.6.完善药品价格监管机制，合理控制药品价格，保障药品市场秩序。Improvethedrugpricemonitoringmechanism,reasonablycontroldrugprices,andensuretheorderofthedrugmarket.7.加强对互联网药品销售的监管，防止非法销售和假冒伪劣药品流入市场。Strengthenthesupervisionofonlinedrugsalestopreventillegalsalesandthecirculationofcounterfeitandinferiordrugsinthemarket.8.加大对药品生产企业的质量管理和GMP认证的监督检查力度。IncreasesupervisionandinspectionofqualitymanagementandGMPcertificationofdrugproductionenterprises.9.完善药品监管法律法规，加强对药品违法行为的打击力度。Improvedrugregulationlawsandregulations,andstrengthenthecrackdownonillegaldrugactivities.10.加强药品监管执法力量建设，提高执法效率和水平。Strengthentheconstructionofdrugregulatoryenforcementforcestoimproveenforcementefficiencyandlevel.